Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone therapy can help postmenopausal women with low sexual desire but needs more safety research and should be used with estrogen therapy.

Testosterone therapy can help with androgen deficiency in women but should be used with caution and monitoring due to potential risks.

Testosterone therapy can help improve sexual function, mood, and bone density in women with low androgen levels, but more research is needed on long-term safety.

The study suggests that a specific gene variation and higher gene activity are linked to increased baldness in Egyptian men.

5α‐reductase isozymes are crucial for prostate development and health, and targeting them can help prevent and treat prostate issues.

Women with polycystic ovary syndrome tend to have a longer anogenital distance.

Women with female pattern hair loss have higher levels of certain androgens, suggesting increased androgen exposure to hair follicles.

DHT is a strong androgen that may pose less risk to the prostate compared to testosterone.

Androgens like testosterone affect hair growth and oil production differently across body parts and individuals.

Human skin cells contain Protease Nexin-1, and male hormones can decrease its levels, potentially affecting hair growth.

Prostate-specific antigen may be a new marker for excess male hormones in women with polycystic ovary syndrome.

The guide recommends specific methods for diagnosing PCOS and various treatments for its symptoms, while considering the health impacts on adolescents.

Men with liver cancer have higher levels of a specific testosterone byproduct in their liver and blood, despite overall lower male hormone levels.

High aldosterone and free testosterone levels link to female hair loss; testing aldosterone may predict hypertension risk.

Jagged1 and Epidermal Growth Factor together significantly increased hair growth in mice with androgen-suppressed hair.

Excessive hair growth in women, often from high androgen levels, is usually caused by PCOS, and can be treated with hair removal, medication, and possibly weight loss.

ERG increases SOX9, promoting prostate cancer growth and invasion.

Two enzymes regulate androgen receptor activity, affecting treatments for androgen insufficiency and benign prostatic hyperplasia.

The new progesterone derivatives effectively inhibit 5α-reductase and bind to the androgen receptor.

A drug called cimetidine can help treat hair loss in women by blocking androgen receptors. However, it's not the first choice and needs more research.

Cyanidin 3-O-arabinoside may help treat a common form of hair loss by protecting cells against aging and improving cell function.

Insufficient androgen action in male fetuses can cause genital development issues due to genetic mutations or environmental chemicals.

Finasteride reduces hairiness and androgen levels in women with unexplained excessive hair growth.

Cytokines and neuropeptides are key in controlling androgen levels, affecting skin and hair conditions.

Finasteride, a hair loss drug, may cause long-term sexual side effects due to changes in hormone receptor levels.

Steroid Sulfatase inhibitors show promise in treating hormone-dependent disorders like cancers, hair loss, and acne, with 667COUMATE being a potential candidate for breast cancer treatment trials.

Genetic defects in testosterone production can cause hormonal and developmental disorders, and more research is needed to understand androgen regulation and develop safer treatments.

5α-reductase inhibitors like finasteride and dutasteride can help treat skin disorders stimulated by androgens, such as hair loss and acne.

Researchers found four natural compounds that can change DHT levels in prostate cancer cells.

Understanding how androgens and their receptors work can lead to improved treatments for skin diseases.